Understanding the BMI and eligibility question Access to tirzepatide often depends on meeting specific BMI criteria, which creates a particular challenge for women with PCOS
45 Products that are a combination of a DPP-4 inhibitor and an SGLT2 inhibitor (sitagliptin/ertugliflozin, saxagliptin/dapagliflozin, and linagliptin/empagliflozin) may be used to further lower A1C and provide increased CV benefit in patients who are not meeting A1C goals on dual therapy
It does not appear to have a direct effect on fetal growth, as hGH-V is not detectable in the fetal circulation and growth hormone receptors are sparse within the fetus.159 However, the somatogenic activities of hGH are mediated by maternal IGF-I, which is a peptide growth factor produced by most tissues that has multiple mitogenic effects on target cells, including increased amino acid transport, increased glucose uptake, enhanced nucleic acid and protein synthesis, and increased cell replication.164 Local and hepatic synthesis of IGF-I is stimulated by hGH-V, and increases in maternal hGH-V during pregnancy are paralleled by increases in IGF-I during the second half of gestation
The market context is large and growing
Although she eventually stopped due to cost, she described the medication as "a miracle" for helping her regain control of her body